761 related articles for article (PubMed ID: 24928203)
21. Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology.
Casoli T; Di Stefano G; Giorgetti B; Grossi Y; Balietti M; Fattoretti P; Bertoni-Freddari C
Ann N Y Acad Sci; 2007 Jan; 1096():170-8. PubMed ID: 17405928
[TBL] [Abstract][Full Text] [Related]
22. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.
Skoglund C; Wetterö J; Tengvall P; Bengtsson T
Immunobiology; 2010 Dec; 215(12):987-95. PubMed ID: 20163886
[TBL] [Abstract][Full Text] [Related]
23. Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease.
Gardella JE; Gorgone GA; Munoz PC; Ghiso J; Frangione B; Gorevic PD
Lab Invest; 1992 Sep; 67(3):303-13. PubMed ID: 1405489
[TBL] [Abstract][Full Text] [Related]
24. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
25. Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis.
Schaff M; Tang C; Maurer E; Bourdon C; Receveur N; Eckly A; Hechler B; Arnold C; de Arcangelis A; Nieswandt B; Denis CV; Lefebvre O; Georges-Labouesse E; Gachet C; Lanza F; Mangin PH
Circulation; 2013 Jul; 128(5):541-52. PubMed ID: 23797810
[TBL] [Abstract][Full Text] [Related]
26. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.
Dubois C; Panicot-Dubois L; Gainor JF; Furie BC; Furie B
J Clin Invest; 2007 Apr; 117(4):953-60. PubMed ID: 17380206
[TBL] [Abstract][Full Text] [Related]
28. Platelets: physiology and biochemistry.
Jurk K; Kehrel BE
Semin Thromb Hemost; 2005; 31(4):381-92. PubMed ID: 16149014
[TBL] [Abstract][Full Text] [Related]
29. Effects of microgravity and hypergravity on platelet functions.
Dai K; Wang Y; Yan R; Shi Q; Wang Z; Yuan Y; Cheng H; Li S; Fan Y; Zhuang F
Thromb Haemost; 2009 May; 101(5):902-10. PubMed ID: 19404544
[TBL] [Abstract][Full Text] [Related]
30. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
[TBL] [Abstract][Full Text] [Related]
31. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
32. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
[TBL] [Abstract][Full Text] [Related]
33. Platelet interaction with the vessel wall.
de Groot PG; Urbanus RT; Roest M
Handb Exp Pharmacol; 2012; (210):87-110. PubMed ID: 22918728
[TBL] [Abstract][Full Text] [Related]
34. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis.
Schütz E; Bochenek ML; Riehl DR; Bosmann M; Münzel T; Konstantinides S; Schäfer K
Thromb Haemost; 2017 Aug; 117(9):1782-1797. PubMed ID: 28726976
[TBL] [Abstract][Full Text] [Related]
35. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.
Woulfe DS; Lilliendahl JK; August S; Rauova L; Kowalska MA; Abrink M; Pejler G; White JG; Schick BP
Blood; 2008 Apr; 111(7):3458-67. PubMed ID: 18094327
[TBL] [Abstract][Full Text] [Related]
36. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease.
Schultheiss C; Blechert B; Gaertner FC; Drecoll E; Mueller J; Weber GF; Drzezga A; Essler M
Angiogenesis; 2006; 9(2):59-65. PubMed ID: 16821113
[TBL] [Abstract][Full Text] [Related]
37. CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
Gupta S; Braun A; Morowski M; Premsler T; Bender M; Nagy Z; Sickmann A; Hermanns HM; Bösl M; Nieswandt B
Circ Res; 2012 Nov; 111(11):1410-20. PubMed ID: 22955732
[TBL] [Abstract][Full Text] [Related]
38. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
[TBL] [Abstract][Full Text] [Related]
39. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo.
Nieswandt B; Moser M; Pleines I; Varga-Szabo D; Monkley S; Critchley D; Fässler R
J Exp Med; 2007 Dec; 204(13):3113-8. PubMed ID: 18086864
[TBL] [Abstract][Full Text] [Related]
40. [Activation and inhibitory mechanisms of blood platelets].
Suzuki-Inoue K
Nihon Rinsho; 2014 Jul; 72(7):1212-7. PubMed ID: 25163310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
